Web Extra: Unseating Methyl Bromide

What happened when a small company thinks it can abolish a multibillion dollar industry?

Written byAlison McCook
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

In the 1980s, a college dropout named Louis Champon left his father's essential oils business to find a plant-based product that repelled animals. He tested various combinations concocted at various locations - including his kitchen sink -- on animals at a shelter. He discovered that one chemical, made up of ingredients from pepper and mustard, doubled as an insect repellant when a sprayed cockroach in his home died instantly. He formed a company, now called Champon Millennium Chemicals, based in Herndon, Va., and set to work making a profit with an alternative to methyl bromide, which, since plant-based, had the potential to be much less toxic to humans and the environment. But proving that turned into a formidable challenge.

Though the Montreal Protocol stipulates that developed countries would phase out the use of methyl bromide by 2005, there are loopholes within the agreement and countries, chief among them the US, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies